Published in Am J Respir Cell Mol Biol on August 14, 2008
An association between L-arginine/asymmetric dimethyl arginine balance, obesity, and the age of asthma onset phenotype. Am J Respir Crit Care Med (2012) 1.85
From arginine methylation to ADMA: a novel mechanism with therapeutic potential in chronic lung diseases. BMC Pulm Med (2009) 1.24
Arginase: a key enzyme in the pathophysiology of allergic asthma opening novel therapeutic perspectives. Br J Pharmacol (2009) 1.16
IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology (2012) 1.09
Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol (2010) 0.99
Aryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosis. Toxicol Sci (2012) 0.93
Potential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosis. Pulm Med (2011) 0.91
Adiposity, fractional exhaled nitric oxide, and asthma in U.S. children. Am J Respir Crit Care Med (2014) 0.89
Acute lung injury-induced collagen deposition is associated with elevated asymmetric dimethylarginine and arginase activity. Shock (2011) 0.84
γ-tocopherol nebulization decreases oxidative stress, arginase activity, and collagen deposition after burn and smoke inhalation in the ovine model. Shock (2012) 0.84
Metabolic Syndrome Is Associated with Increased Oxo-Nitrative Stress and Asthma-Like Changes in Lungs. PLoS One (2015) 0.80
Pseudomonas aeruginosa is associated with increased lung cytokines and asymmetric dimethylarginine compared with methicillin-resistant Staphylococcus aureus. Shock (2011) 0.79
Arginine and nitric oxide pathways in obesity-associated asthma. J Allergy (Cairo) (2013) 0.78
Serum methylarginines and spirometry-measured lung function in older adults. PLoS One (2013) 0.77
Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthma. PLoS One (2014) 0.77
Asymmetric dimethylarginine blocks nitric oxide-mediated alcohol-stimulated cilia beating. Mediators Inflamm (2013) 0.76
Positive correlation of airway resistance and serum asymmetric dimethylarginine level in COPD patients with systemic markers of low-grade inflammation. Int J Chron Obstruct Pulmon Dis (2017) 0.75
l-citrulline prevents asymmetric dimethylarginine-mediated reductions in nitric oxide and nitrosative stress in primary human airway epithelial cells. Clin Exp Allergy (2016) 0.75
Relationship of Oxidant and Antioxidant Markers to Asthma Severity in Egyptian Asthmatic Children. Open Access Maced J Med Sci (2017) 0.75
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet (1992) 5.36
Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J Immunol (1990) 4.36
Nitric oxide in health and disease of the respiratory system. Physiol Rev (2004) 3.15
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet (2002) 2.92
Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation (1999) 2.77
Regulation of enzymes of the urea cycle and arginine metabolism. Annu Rev Nutr (2002) 2.70
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation (2002) 2.65
Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J (2004) 2.37
Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation (2003) 2.30
Analysis of methylarginine metabolism in the cardiovascular system identifies the lung as a major source of ADMA. Am J Physiol Lung Cell Mol Physiol (2006) 2.29
Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation (1997) 2.20
Inhalation of nitric oxide modulates methacholine-induced bronchoconstriction in the rabbit. Eur Respir J (1993) 1.95
Purification and properties of a new enzyme, NG,NG-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem (1989) 1.94
Molecular mechanisms of increased nitric oxide (NO) in asthma: evidence for transcriptional and post-translational regulation of NO synthesis. J Immunol (2000) 1.84
Nitric oxide and lung disease. Thorax (1993) 1.77
Protein methylase I. Purification and properties of the enzyme. J Biol Chem (1968) 1.75
Multiple roles of nitric oxide in the airways. Thorax (2003) 1.69
Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium. Am Rev Respir Dis (1993) 1.69
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res (2003) 1.67
Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. J Am Soc Nephrol (2007) 1.54
Endogenous dimethylarginine as an inhibitor of nitric oxide synthesis. J Cardiovasc Pharmacol (1992) 1.51
MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J Immunol (1993) 1.49
The human arginases and arginase deficiency. J Inherit Metab Dis (1998) 1.46
Increased arginase activity underlies allergen-induced deficiency of cNOS-derived nitric oxide and airway hyperresponsiveness. Br J Pharmacol (2002) 1.44
Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol (1998) 1.42
Plasma levels of asymmetrical dimethyl-L-arginine in patients with congenital heart disease and pulmonary hypertension. J Cardiovasc Pharmacol (2001) 1.40
Inhibition of arginase I activity by RNA interference attenuates IL-13-induced airways hyperresponsiveness. J Immunol (2006) 1.40
Arginine metabolism in vascular biology and disease. Vasc Med (2005) 1.34
The dual personality of NO. Trends Pharmacol Sci (2000) 1.33
Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Circ Res (2007) 1.31
Metabolism of methylarginines by human vasculature; implications for the regulation of nitric oxide synthesis. Br J Pharmacol (1994) 1.28
Increased endogenous nitric oxide synthase inhibitor in patients with congestive heart failure. Life Sci (1998) 1.25
Studies on the catabolism of Ng-methylarginine, Ng, Ng-dimethylarginine and Ng, Ng-dimethylarginine in the rabbit. Biochem J (1976) 1.22
Nitric oxide inhibits inflammatory cytokine production by human alveolar macrophages. Am J Respir Cell Mol Biol (1997) 1.21
Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med (2005) 1.21
Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int (1994) 1.20
Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol (2006) 1.19
Genetic polymorphisms in arginase I and II and childhood asthma and atopy. J Allergy Clin Immunol (2005) 1.19
Collagen deposition in a non-fibrotic lung granuloma model after nitric oxide inhibition. Am J Pathol (1998) 1.16
Deficiency of nitric oxide in allergen-induced airway hyperreactivity to contractile agonists after the early asthmatic reaction: an ex vivo study. Br J Pharmacol (1996) 1.16
Randomised double-blind placebo-controlled study of the effect of inhibition of nitric oxide synthesis in bradykinin-induced asthma. Lancet (1996) 1.13
An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol (2000) 1.10
Effects of nitric oxide synthases in chronic allergic airway inflammation and remodeling. Am J Respir Cell Mol Biol (2006) 1.07
Role of asymmetric dimethylarginine for angiotensin II-induced target organ damage in mice. Am J Physiol Heart Circ Physiol (2007) 1.07
Functional role and species-specific contribution of arginases in pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2007) 1.07
Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice. Respir Res (2006) 1.07
Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases. Biochim Biophys Acta (1995) 1.06
Inhibition of arginase by NG-hydroxy-L-arginine in alveolar macrophages: implications for the utilization of L-arginine for nitric oxide synthesis. FEBS Lett (1995) 1.06
Matrix metalloproteinase-9 and airway remodeling in asthma. Curr Drug Targets Inflamm Allergy (2005) 1.05
Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res (2003) 1.02
Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma. Respir Res (2006) 1.02
NG-hydroxy-L-arginine and nitric oxide inhibit Caco-2 tumor cell proliferation by distinct mechanisms. Am J Physiol (1998) 1.01
Nitric oxide increased interleukin-4 expression in T lymphocytes. Immunology (1997) 0.98
Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J Allergy Clin Immunol (2001) 0.97
Invasive versus noninvasive measurement of allergic and cholinergic airway responsiveness in mice. Respir Res (2005) 0.96
Transiently, paralleled upregulation of arginase and nitric oxide synthase and the effect of both enzymes on the pathology of asthma. Am J Physiol Lung Cell Mol Physiol (2007) 0.94
Arginase attenuates inhibitory nonadrenergic noncholinergic nerve-induced nitric oxide generation and airway smooth muscle relaxation. Respir Res (2005) 0.93
Increased protein arginine methylation in chronic hypoxia: role of protein arginine methyltransferases. Am J Respir Cell Mol Biol (2006) 0.92
Inducible nitric oxide synthase after sensitization and allergen challenge of Brown Norway rat lung. Br J Pharmacol (1997) 0.90
Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol (2000) 0.89
Airway response to deep inspiration: role of nitric oxide. Eur Respir J (2003) 0.89
Effects of endogenous superoxide anion and nitric oxide on cholinergic constriction of normal and hyperreactive guinea pig airways. Am J Respir Crit Care Med (1998) 0.88
Endogenous nitric oxide counteracts antigen-induced bronchoconstriction. Eur J Pharmacol (1993) 0.87
Distribution and properties of arginase in the salivary glands of four species of laboratory mammals. J Comp Physiol B (2004) 0.80
Particle length-dependent titanium dioxide nanomaterials toxicity and bioactivity. Part Fibre Toxicol (2009) 2.06
Interlaboratory evaluation of in vitro cytotoxicity and inflammatory responses to engineered nanomaterials: the NIEHS Nano GO Consortium. Environ Health Perspect (2013) 1.68
Silica binding and toxicity in alveolar macrophages. Free Radic Biol Med (2007) 1.65
MARCO mediates silica uptake and toxicity in alveolar macrophages from C57BL/6 mice. J Biol Chem (2006) 1.54
Trees as reservoirs for amphibole fibers in Libby, Montana. Sci Total Environ (2006) 1.23
Scavenger receptor class A type I/II (CD204) null mice fail to develop fibrosis following silica exposure. Am J Physiol Lung Cell Mol Physiol (2005) 1.23
A comparison of dispersing media for various engineered carbon nanoparticles. Part Fibre Toxicol (2007) 1.21
Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells. Am J Respir Cell Mol Biol (2006) 1.19
Silica-directed mast cell activation is enhanced by scavenger receptors. Am J Respir Cell Mol Biol (2006) 1.18
Effect of multi-walled carbon nanotube surface modification on bioactivity in the C57BL/6 mouse model. Nanotoxicology (2013) 1.17
Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts. Toxicol Sci (2012) 1.15
Critical role of MARCO in crystalline silica-induced pulmonary inflammation. Toxicol Sci (2009) 1.11
Innate immune processes are sufficient for driving silicosis in mice. J Leukoc Biol (2010) 1.11
The Big Sky Model: A Regional Collaboration for Participatory Research on Environmental Health in the Rural West. J High Educ Outreach Engagem (2008) 1.10
Prostaglandin I2-IP signaling blocks allergic pulmonary inflammation by preventing recruitment of CD4+ Th2 cells into the airways in a mouse model of asthma. J Immunol (2007) 1.09
IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology (2012) 1.09
IL-1R signalling is critical for regulation of multi-walled carbon nanotubes-induced acute lung inflammation in C57Bl/6 mice. Nanotoxicology (2012) 1.04
NLRP3 inflammasome activation in murine alveolar macrophages and related lung pathology is associated with MWCNT nickel contamination. Inhal Toxicol (2012) 1.00
Asymmetric dimethylarginine potentiates lung inflammation in a mouse model of allergic asthma. Am J Physiol Lung Cell Mol Physiol (2010) 0.99
The IL-4Ralpha pathway in macrophages and its potential role in silica-induced pulmonary fibrosis. J Leukoc Biol (2007) 0.99
Purification and sidewall functionalization of multiwalled carbon nanotubes and resulting bioactivity in two macrophage models. Inhal Toxicol (2013) 0.98
Surface components of airborne particulate matter induce macrophage apoptosis through scavenger receptors. Toxicol Appl Pharmacol (2002) 0.97
Increase in a distinct pulmonary macrophage subset possessing an antigen-presenting cell phenotype and in vitro APC activity following silica exposure. Toxicol Appl Pharmacol (2005) 0.97
Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal Toxicol (2004) 0.97
COPD is associated with a macrophage scavenger receptor-1 gene sequence variation. Chest (2010) 0.97
Silica, apoptosis, and autoimmunity. J Immunotoxicol (2005) 0.96
Differential binding of inorganic particles to MARCO. Toxicol Sci (2008) 0.95
Silica-exposed mice generate autoantibodies to apoptotic cells. Toxicology (2004) 0.95
Nonpulmonary outcomes of asbestos exposure. J Toxicol Environ Health B Crit Rev (2011) 0.93
Antigen-presenting cell population dynamics during murine silicosis. Am J Respir Cell Mol Biol (2007) 0.93
Role of scavenger receptor a family in lung inflammation from exposure to environmental particles. J Immunotoxicol (2008) 0.92
Potential role of the inflammasome-derived inflammatory cytokines in pulmonary fibrosis. Pulm Med (2011) 0.91
Murine pulmonary inflammation model: a comparative study of anesthesia and instillation methods. Inhal Toxicol (2010) 0.91
Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New Zealand mixed mice. Am J Physiol Lung Cell Mol Physiol (2005) 0.87
Airway responsiveness after acute exposure to urban particulate matter 1648 in a DO11.10 murine model. Am J Physiol Lung Cell Mol Physiol (2003) 0.87
Extracellular HMGB1 regulates multi-walled carbon nanotube-induced inflammation in vivo. Nanotoxicology (2014) 0.86
A comparison of murine and human alveolar macrophage responses to urban particulate matter. Inhal Toxicol (2004) 0.84
Toxicity of lunar and martian dust simulants to alveolar macrophages isolated from human volunteers. Inhal Toxicol (2008) 0.83
Silica suppresses Toll-like receptor ligand-induced dendritic cell activation. FASEB J (2008) 0.83
Urinary levoglucosan as a biomarker of wood smoke: results of human exposure studies. J Expo Sci Environ Epidemiol (2009) 0.83
Three human cell types respond to multi-walled carbon nanotubes and titanium dioxide nanobelts with cell-specific transcriptomic and proteomic expression patterns. Nanotoxicology (2013) 0.83
Pulmonary toxicity of simulated lunar and Martian dusts in mice: II. Biomarkers of acute responses after intratracheal instillation. Inhal Toxicol (2002) 0.83
Air pollution particulate SRM 1648 causes oxidative stress in RAW 264.7 macrophages leading to production of prostaglandin E2, a potential Th2 mediator. Inhal Toxicol (2005) 0.82
A comparison of asbestos and urban particulate matter in the in vitro modification of human alveolar macrophage antigen-presenting cell function. Exp Lung Res (2004) 0.82
Alveolar macrophages from systemic sclerosis patients: evidence for IL-4-mediated phenotype changes. Am J Physiol Lung Cell Mol Physiol (2004) 0.82
Acute inhalation exposure to vaporized methamphetamine causes lung injury in mice. Inhal Toxicol (2008) 0.81
Role of the serotonergic system in reduced pulmonary function after exposure to methamphetamine. Am J Respir Cell Mol Biol (2009) 0.81
Patterns of asthma symptoms and perceptions of harm from seasonal atmospheric events in rural Western Montana. Int J Occup Environ Health (2006) 0.77
Modified low density lipoproteins binding requires a lysine cluster region in the murine macrophage scavenger receptor class A type II. Mol Biol Rep (2009) 0.76
Correction: Silica-Triggered Autoimmunity in Lupus-Prone Mice Blocked by Docosahexaenoic Acid Consumption. PLoS One (2017) 0.75
Particulate matter immunomodulatory effects on autoantibody development in New Zealand mixed mice. J Immunotoxicol (2004) 0.75
Effects of toxic gases: methamphetamine inhalation. J Burn Care Res (2009) 0.75